Jamil Khurram bought GALT
December 17, 2025 · Form 4 insider transaction
Jamil Khurram bought 8,500 shares of Galectin Therapeutics Inc. at $2.50 per share, a transaction worth $21.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,500
Price
$2.50
Total value
$21.3K
InsiderJamil Khurram
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 17, 2025
Filing dateDecember 19, 2025
Shares owned after8,500
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on July 15, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.